Serum biomarker screen for the diagnosis of clinical and preclinical alzheimer's disease

• 1. 一种用于筛查或辅助诊断胃癌的生物标志物组合及其试剂盒和应用 [P] . 中国专利： CN111471764A . 2020-07-31
• 2. 一种用于诊断原发性肝癌的血清特异性生物标志物及筛选方法与应用 [P] . 中国专利： CN107937519B . 2021.11.02
• 3. Serum Biomarker Screen for the Diagnosis of Clinical and Preclinical Alzheimer's Disease [P] . 美国专利： US2020271674A1 . 2020-08-27

  机译： 血清生物标志物筛查可用于临床和临床前阿尔茨海默氏病的诊断

• 4. Serum Biomarker Screen for the Diagnosis of Clinical and Preclinical Alzheimer's Disease [P] . 美国专利： US2014018446A1 . 2014-01-16

  机译： 血清生物标志物筛查可用于临床和临床前阿尔茨海默氏病的诊断

• 5. Method early preclinical diagnosis of Parkinson's disease on the basis of biomarkers in blood analysis in patients and in experimental models of early clinical and preclinical stages of the disease [P] . 俄罗斯专利： RU2016137444A . 2018-03-23

  机译： 根据患者血液分析中的生物标志物以及疾病早期和临床前阶段的实验模型中的生物标记物，对帕金森氏病进行早期临床前诊断方法

• 1. Leukocyte telomere length and plasma interleukin-1β and interleukin-18 levels in mild cognitive impairment and Alzheimer 's disease: new biomarkers for diagnosis and disease progression? [J] . Rosa Maria Corbo, Rita Businaro, Daniela Scarabino 中国神经再生研究（英文版） . 2021,第007期
• 2. Characterization of microRNAs in serum:a novel class of biomarkers for diagnosis of cancer and other diseases [J] . Xi Chen, Xing Guo, Qibin Li, 细胞研究（英文版） . 2008,第010期
• 3. Characterization of microRNAs in serum： a novel class of biomarkers for diagnosis of cancer and other diseases [J] . Xi Chen, Yi Ba, Lijia Ma, 细胞研究：英文版 . 2008,第010期
• 4. The Serum Exosome Derived MicroRNA-135a,-193b,and-384 Were Potential Alzheimer's Disease Biomarkers [J] . YANG Ting Ting, LIU Chen Geng, GAO Shi Chao, 生物医学与环境科学（英文版） . 2018,第002期
• 5. Proteomic analysis of serum proteins in triple transgenic alzheimer's disease mice: Implications for identifying biomarkers for use to screen potential candidate therapeutic drugs for early alzheimer's disease [J] . SuiX., RenX., HuangP., Journal of Alzheimer's disease: JAD . 2014,第3期
• 6. Cerebrospinal fluid biomarkers and proximity to diagnosis in preclinical familial Alzheimer's disease [J] . RingmanJ.M., CoppolaG., ElashoffD., Dementia and geriatric cognitive disorders . 2012,第1期
• 7. Exosome Biomarkers Revolutionize Preclinical Diagnosis of Neurodegenerative Diseases and Assessment of Treatment Responses in Clinical Trials [J] . Kapogiannis Dimitrios Advances in Experimental Medicine and Biology . 2020,第1期
• 8. Machine Learning Models Reveal the Importance of Clinical Biomarkers for the Diagnosis of Alzheimer’s Disease [C] . Mahmoud Ahmed Refaee, Amal Awadalla Mohamed Ali, Asma Hamid Elfadl, International Conference on Informatics, Management, and Technology in Healthcare . 2020
• 9. Electrochemical Biosensors for Neurodegenerative Disease Biomarkers: Investigations into the Origin and Diagnosis of Alzheimer’s Disease and Amyotrophic Lateral Sclerosis [D] . Wallace, William. 2021
• 10. Cerebrospinal Fluid Biomarkers and Proximity to Diagnosis in Preclinical Familial Alzheimers Disease [O] . John M. Ringman, Giovanni Coppola, David Elashoff, -1
• 11. Prospective Therapies for Alzheimer Disease: Biomarkers, Clinical Trials and Preclinical Research [O] . Jofre Guell-Bosch, Gisela Esquerda-Canals, Laia Montoliu-Gaya, 2016

• 1. IL-1β, TNF-α and Sambucus nigra Reactive Serum Proteins as Biomarkers of Mild Cognitive Impairment and Alzheimer Disease Progression [J] . Luis Manuel Castillo ,Enrique Moreno ,Yaneth Rodriguez-Agudelo . 阿尔茨海默氏病研究进展（英文） . 2015,第4期
• 2. 血清、胆汁CA19-9在胰腺癌诊断中的临床价值评价及最佳筛查界值ROC分析 [C] . YAN Jun ,严俊 ,LI Xun . 2015第八届全国ERCP学术研讨会暨第十一届中国西部国际治疗内镜高峰论坛 . 2015
• 3. 血清miRNAs作为生物标志物应用于非小细胞肺癌的早期诊断 [A] . 李典和 . 2017